Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

Transcatheter aortic valve implantation (TAVI) has been established as an effective treatment modality in patients with severe aortic stenosis and the uptake of TAVI is rapidly growing in the Asia-Pacific region. However, there exists a heterogeneity in the management of aortic stenosis and the use of TAVI among countries in the region. Reasons for these differences include anatomical variations, disparity in healthcare resources and infrastructure and the lack of consensus on the optimal management of aortic stenosis in the Asia-Pacific region. Hence, an Asian Pacific Society of Cardiology (APSC) working group, including a multidisciplinary group of general and interventional cardiologists, cardiac surgeons and imaging specialists, developed a position statement on the recommendations for TAVI in the management of aortic stenosis. The APSC expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were in support of ‘agree’ or ‘neutral.’ The resulting 28 statements provide guidance for clinical practitioners in the region on the use of TAVI in the treatment of patients with aortic stenosis.

Authors

Institutions

Publication Details

Journal
Journal of Asian Pacific Society of Cardiology
Published
2024-10-31
DOI
https://doi.org/10.15420/japsc.2024.26
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

Shaiful Azmi Yahaya, Timothy C Dy, Michael Lee, Minoru Tabata et al.
Journal of Asian Pacific Society of Cardiology
Cardiac Valve Diseases and Treatments
article

Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

Shaiful Azmi Yahaya, Timothy C Dy, Michael Lee, Minoru Tabata, See Hooi Ewe, Jonathan Jiunn Liang Yap, Yung‐Tsai Lee, Serigne Lo, Masaki Izumo, Angus Shing Fung Chui, Jimmy Kim Fatt Hon, Simon Cheung-Chi Lam, Kentaro Hayashida, Jack Wei Chieh Tan, Duk-Woo Park, Mann Chandavimol, Kay Woon Ho, Ashok Seth, Nattawut Wongpraparut, Edgar Tay, Jianan Wang, Chen Mao, Quang Ngoc Nguyen, Wei‐Hsian Yin, Hyo-Soo Kim, Dion Stub, Karl Poon, Rajesh Nair, Gilbert Tang, Ravinder Singh Rao, Kenny YK Sin
article en

Abstract

Transcatheter aortic valve implantation (TAVI) has been established as an effective treatment modality in patients with severe aortic stenosis and the uptake of TAVI is rapidly growing in the Asia-Pacific region. However, there exists a heterogeneity in the management of aortic stenosis and the use of TAVI among countries in the region. Reasons for these differences include anatomical variations, disparity in healthcare resources and infrastructure and the lack of consensus on the optimal management of aortic stenosis in the Asia-Pacific region. Hence, an Asian Pacific Society of Cardiology (APSC) working group, including a multidisciplinary group of general and interventional cardiologists, cardiac surgeons and imaging specialists, developed a position statement on the recommendations for TAVI in the management of aortic stenosis. The APSC expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were in support of ‘agree’ or ‘neutral.’ The resulting 28 statements provide guidance for clinical practitioners in the region on the use of TAVI in the treatment of patients with aortic stenosis.

Journal of Asian Pacific Society of CardiologyVol. 3
Ulsan College (KR), Mount Sinai Health System (US), Siriraj Hospital (TH), National Yang Ming Chiao Tung University (TW), Nelson Marlborough Institute of Technology (NZ), St. Marianna University School of Medicine (JP), The University of Queensland (AU), Hanoi Medical University (VN), Keio University (JP), Sichuan University (CN), Mahidol University (TH), Queen Mary Hospital (CN), Liverpool Hospital (AU), Chinese General Hospital and Medical Center (PH), Asan Medical Center (KR), Seoul National University Hospital (KR), University of Ulsan (KR), West China Hospital of Sichuan University (CN), Cheng Hsin General Hospital (TW), Fortis Escorts Heart Institute (IN), Prince Charles Hospital (AU), Duke-NUS Medical School (SG), National Heart Institute (MY), Ramathibodi Hospital (TH), National University Hospital (SG), National Heart Centre Singapore (SG), Second Affiliated Hospital of Zhejiang University (CN), Sengkang General Hospital (SG), Queen Elizabeth Hospital (CN), Monash University (AU)
Industry, innovation and infrastructure
Openalex Percentile: Top 65%
Cardiac Valve Diseases and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.